Cupid moves up on securing initial order from Cipla Health for male condoms
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Cupid is currently trading at Rs. 95.41, up by 0.50 points or 0.53% from its previous closing of Rs. 94.91 on the BSE.
The scrip opened at Rs. 96.00 and has touched a high and low of Rs. 96.85 and Rs. 95.40 respectively. So far 44623 shares were traded on the counter.
The BSE group 'T' stock of face value Rs. 1 has touched a 52 week high of Rs. 141.65 on 02-Mar-2024 and a 52 week low of Rs. 12.06 on 10-Jul-2023.
Last one week high and low of the scrip stood at Rs. 97.95 and Rs. 94.75 respectively. The current market cap of the company is Rs. 2577.28 crore.
The promoters holding in the company stood at 44.80%, while Institutions and Non-Institutions held 5.20% and 50.00% respectively.
Cupid has received an initial order from Cipla Health to manufacture a range of male condoms under the Cipla brand. Following this initial rollout, Cipla Health has committed to placing regular, sizeable orders for male condoms with Cupid in the coming quarters. Securing this initial order is a significant milestone for the company, and it looks forward to growing its business with Cipla Health.
Cupid manufactures and markets varieties of male and female condoms, water based lubricant, latex dental dams and probe covers. Cupid has a diverse product basket available in many countries worldwide.
